Werner J. Struss

988 total citations
23 papers, 713 citations indexed

About

Werner J. Struss is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Cancer Research. According to data from OpenAlex, Werner J. Struss has authored 23 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 11 papers in Surgery and 8 papers in Cancer Research. Recurrent topics in Werner J. Struss's work include Prostate Cancer Treatment and Research (10 papers), Cancer Genomics and Diagnostics (8 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Werner J. Struss is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Cancer Genomics and Diagnostics (8 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Werner J. Struss collaborates with scholars based in Canada, Germany and United Kingdom. Werner J. Struss's co-authors include Alexander W. Wyatt, Kim N., Peter C. Black, Alan So, Martin Gleave, Matti Annala, Gillian Vandekerkhove, Kevin Beja, Matti Nykter and Klaus‐Peter Dieckmann and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

Werner J. Struss

22 papers receiving 704 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Werner J. Struss Canada 11 440 279 241 230 180 23 713
Juliette Haudebourg France 14 268 0.6× 119 0.4× 206 0.9× 208 0.9× 144 0.8× 37 651
Heike Loeser Germany 17 274 0.6× 136 0.5× 280 1.2× 266 1.2× 219 1.2× 30 731
Anna Zamboli Italy 13 401 0.9× 117 0.4× 519 2.2× 283 1.2× 151 0.8× 19 821
Renyan Gong China 7 475 1.1× 195 0.7× 425 1.8× 586 2.5× 137 0.8× 9 961
Meltem Ekenel Türkiye 13 282 0.6× 103 0.4× 297 1.2× 117 0.5× 110 0.6× 51 601
Pei Dong China 16 276 0.6× 176 0.6× 157 0.7× 214 0.9× 313 1.7× 60 666
Jennifer A. Dorth United States 15 272 0.6× 76 0.3× 371 1.5× 248 1.1× 162 0.9× 60 837
Rossella De Cecio Italy 17 248 0.6× 117 0.4× 393 1.6× 139 0.6× 171 0.9× 47 706
Wai Chin Foo United States 15 287 0.7× 116 0.4× 389 1.6× 297 1.3× 152 0.8× 51 820
Rou Jiang China 17 288 0.7× 193 0.7× 480 2.0× 398 1.7× 168 0.9× 22 987

Countries citing papers authored by Werner J. Struss

Since Specialization
Citations

This map shows the geographic impact of Werner J. Struss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Werner J. Struss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Werner J. Struss more than expected).

Fields of papers citing papers by Werner J. Struss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Werner J. Struss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Werner J. Struss. The network helps show where Werner J. Struss may publish in the future.

Co-authorship network of co-authors of Werner J. Struss

This figure shows the co-authorship network connecting the top 25 collaborators of Werner J. Struss. A scholar is included among the top collaborators of Werner J. Struss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Werner J. Struss. Werner J. Struss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chedgy, Edmund C.P., Raymond Tang, Werner J. Struss, et al.. (2023). A randomized controlled trial investigating rectus sheath catheters following radical cystectomy. British Journal of Urology. 132(5). 554–559.
2.
3.
Vandekerkhove, Gillian, Werner J. Struss, Matti Annala, et al.. (2019). Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer. European Urology. 75(4). 667–675. 134 indexed citations
4.
Raven, Peter A., Zheng Tan, Igor Moskalev, et al.. (2019). Inhibition of GLI2 with antisense‐oligonucleotides: A potential therapy for the treatment of bladder cancer. Journal of Cellular Physiology. 234(11). 20634–20647. 11 indexed citations
5.
Vandekerkhove, Gillian, Jean‐Michel Lavoie, Matti Annala, et al.. (2019). Genomic concordance between profiling of circulating tumor DNA (ctDNA) and matched tissue in metastatic urothelial carcinoma.. Journal of Clinical Oncology. 37(7_suppl). 457–457. 2 indexed citations
6.
Lavoie, Jean‐Michel, Gillian Vandekerkhove, Matti Annala, et al.. (2019). Circulating tumor DNA in patients with metastatic urothelial cancer: concordance of genomic findings with matched tissue biopsies.. Journal of Clinical Oncology. 37(15_suppl). e16036–e16036. 2 indexed citations
7.
Todenhöfer, Tilman, Werner J. Struss, Roland Seiler, Alexander W. Wyatt, & Peter C. Black. (2018). Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder Cancer. Bladder Cancer. 4(1). 19–29. 42 indexed citations
8.
Struss, Werner J., Gillian Vandekerkhove, Matti Annala, et al.. (2018). Detection of circulating tumor DNA in de novo metastatic castrate sensitive prostate cancer. Annals of Oncology. 29. viii273–viii273. 2 indexed citations
9.
Frees, Sebastian, Shusuke Akamatsu, Samir Bidnur, et al.. (2018). The impact of time to metastasis on overall survival in patients with prostate cancer. World Journal of Urology. 36(7). 1039–1046. 20 indexed citations
10.
Yip, Steven, Daniel Khalaf, Werner J. Struss, et al.. (2018). Outcomes in patients (Pts) with advanced prostate cancer and inactivating germline mutations in BRCA2 or ATM.. Journal of Clinical Oncology. 36(6_suppl). 242–242. 3 indexed citations
11.
Khalaf, Daniel, Werner J. Struss, Bernhard J. Eigl, et al.. (2018). Efficacy and tolerability of first-line abiraterone + prednisone (ABI) versus enzalutamide (ENZ) for metastatic castration-resistant prostate cancer (mCRPC) in men ≥ 80 years: A retrospective cohort study.. Journal of Clinical Oncology. 36(15_suppl). 5051–5051. 8 indexed citations
12.
Frees, Sebastian, Kyung Seok Han, Zheng Tan, et al.. (2018). The role of netrin-1 in metastatic renal cell carcinoma treated with sunitinib. Oncotarget. 9(32). 22631–22641. 3 indexed citations
13.
Frees, Sebastian, Jonathan Aning, Peter C. Black, et al.. (2017). A prospective randomized pilot study evaluating an ERAS protocol versus a standard protocol for patients treated with radical cystectomy and urinary diversion for bladder cancer. World Journal of Urology. 36(2). 215–220. 62 indexed citations
14.
Vandekerkhove, Gillian, Tilman Todenhöfer, Matti Annala, et al.. (2017). Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer. Clinical Cancer Research. 23(21). 6487–6497. 122 indexed citations
15.
Annala, Matti, Werner J. Struss, Evan W. Warner, et al.. (2017). Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair–deficient Prostate Cancer. European Urology. 72(1). 34–42. 169 indexed citations
16.
Struss, Werner J., Matti Annala, Evan W. Warner, et al.. (2017). Germline DNA repair mutations in metastatic castration-resistant prostate cancer: Therapy response and applicability of circulating tumor DNA.. Journal of Clinical Oncology. 35(6_suppl). 140–140. 2 indexed citations
17.
Struss, Werner J., Zheng Tan, Igor Moskalev, et al.. (2017). Magnetically‐actuated drug delivery device (MADDD) for minimally invasive treatment of prostate cancer: An in vivo animal pilot study. The Prostate. 77(13). 1356–1365. 6 indexed citations
18.
Vandekerkhove, Gillian, Werner J. Struss, Matti Annala, et al.. (2017). Using liquid biopsy to assess the genomic landscape of metastatic urothelial carcinoma. European Urology Supplements. 16(3). e677–e678. 1 indexed citations
19.
Dieckmann, Klaus‐Peter, et al.. (2013). Paratesticular fibrous pseudotumor in young males presenting with histological features of IgG4-related disease: two case reports. Journal of Medical Case Reports. 7(1). 225–225. 24 indexed citations
20.
Dieckmann, Klaus‐Peter, Werner J. Struss, & Ulrich Budde. (2011). Evidence for acute vascular toxicity of cisplatin-based chemotherapy in patients with germ cell tumour.. PubMed. 31(12). 4501–5. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juliette Haudebourg Breakdown of academic impact, for papers by Heike Loeser Breakdown of academic impact, for papers by Anna Zamboli Breakdown of academic impact, for papers by Renyan Gong Breakdown of academic impact, for papers by Meltem Ekenel Breakdown of academic impact, for papers by Pei Dong Breakdown of academic impact, for papers by Jennifer A. Dorth Breakdown of academic impact, for papers by Rossella De Cecio Breakdown of academic impact, for papers by Wai Chin Foo Breakdown of academic impact, for papers by Rou Jiang
Rankless by CCL
2026